Xtant Medical Holdings Reports Q3 2026 Results: Revenue of $24. ...
Biologics Growth Offsets Divestiture Impact; Company Withdraws Full-Year Guidance Related Stocks: XTNT ,
Biologics Growth Offsets Divestiture Impact; Company Withdraws Full-Year Guidance Related Stocks: XTNT ,